Safety and efficacy of the novel RNA interference therapies for hypertriglyceridemia and mixed hyperlipidemia management: a systematic review and meta-analysis
-
Published:2024-09
Issue:
Volume:
Page:
-
ISSN:1530-891X
-
Container-title:Endocrine Practice
-
language:en
-
Short-container-title:Endocrine Practice
Author:
Kamrul-Hasan A.B.M.ORCID,
Dutta Deep,
Nagendra Lakshmi,
Mondal Sunetra,
Bhattacharya Saptarshi,
Kalra Sanjay
Reference40 articles.
1. Triglycerides and cardiovascular disease;Nordestgaard;Lancet,2014
2. Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol;Nichols;J Clin Endocrinol Metab,2018
3. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology;Nordestgaard;Circ Res,2016
4. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society;Ginsberg;Eur Heart J,2021
5. Hypertriglyceridemia - Common Causes, Prevention and Treatment Strategies;Rygiel;Curr Cardiol Rev,2018